(redirected from Esophageal cancer)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.


Fifth letter of a Nasdaq stock symbol specifying that it is the third preferred bond of the company.
Copyright © 2012, Campbell R. Harvey. All Rights Reserved.


1. On a stock transaction table, a symbol indicating that a dividend was paid after a stock split.

2. A symbol appearing next to a bond listed on NASDAQ indicating that the bond is a company's third preferred bond. All NASDAQ listings use a four-letter abbreviation; if the letter "I" follows the abbreviation, this indicates that the security being traded is a third preferred bond.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved


Used in the dividend column of stock transaction tables to indicate that the dividend was paid after a stock dividend or split: Lehigh s.20i.
Wall Street Words: An A to Z Guide to Investment Terms for Today's Investor by David L. Scott. Copyright © 2003 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Lymph node metastasis is the most common route of metastasis of esophageal cancer, of which squamous carcinoma accounts for 95%, with the main site of occurrence in the thoracic esophagus.10 Therefore, this study retrospectively analyzed the lymph node metastasis pattern and the impact of clinical pathological factors on lymphatic metastasis in 1034 cases of ESCC patients undergoing surgery, which has important guiding significance for the development of a reasonable radiation field.
Effective palliation for inoperable esophageal cancer using intensive intracavitary radiation.
Referring to T2-weighted imaging and contrast-enhanced T1-weight-ed imaging, all regions of interest (ROIs) of esophageal cancer were manually set, encompassing the entire tumor area but excluding necrosis, peripheral fat, and blood vessels.
Although several histological subtypes of esophageal cancer have been described to date, esophageal squamous cell carcinoma (ESCC), arising from squamous epithelial cells, and esophageal adenocarcinoma (EAC), arising from glandular epithelial cells, are the most common, together representing more than 90% of all esophageal cancer cases.
of patients Male 12 (100%) Median age (years) 57.0 (51.5-62.75) Etiology Esophageal cancer 10 (83.3%) GIST 1 (8.3%) Esophageal diverticulum 1 (8.3%) Methods of primary surgery Open Ivor Lewis esophagectomy 7 (58.3%) Robotic-assisted Ivor Lewis esophagectomy 4(33.3%) Robotic esophageal diverticulectomy 1 (8.3%) Data are presented as a median value (interquartile range) or number (%).
Epidermal growth factor receptor (EGFR), a transmembrane receptor kinase, is frequently overexpressed in various types of human cancers, including esophageal cancer [3, 4].
Due to the tumor-related dysphagia, vomiting, reduced oral intake, and altered nutrient metabolism associated with systemic inflammation, weight loss is also a common presenting symptom of esophageal cancer [911].
A 41-year-old woman, gravida 2, para 1, was diagnosed with esophageal cancer relapse at 16 weeks of gestation.
About 24% of patients with esophageal cancer are complicated with depression.[sup][1] Previous studies showed that patients with depression have impairment of theory of mind (ToM) abilities.
Esophageal cancer is on the rise in the U.S.--according to the American Cancer Society, an estimated 17,000 new cases were diagnosed in 2016.
Further, the risk of this type of esophageal cancer is lower than previously believed after that first year, according to a study of 7,932 Swedish residents who were diagnosed with BE from 2006 to 2013.

Full browser ?